Si
Siam Bioscience
Bangkok THFounded 2009400 employees
Private CapbiotechPrivateInfectious Disease
Platform: AZ Vaccine Mfg
Market Cap
N/A
All Drugs
4
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SIA-2247 | SIA-2247 | Preclinical | 1 | FLT3 | CTCLLGS | ||
| Elrabrutinib | SIA-6343 | Phase 2 | 1 | USP1 | Gastric CaCervical Ca | ||
| SIA-1629 | SIA-1629 | Phase 2/3 | 1 | KIF18A | FLCSU | ||
| SIA-643 | SIA-643 | Phase 1 | 1 | BCL-2 | MCCMS |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)